Applied Therapeutics Aktie

0,0903 EUR +0,0003 EUR +0,33 %

30.12.2025

BMN

0,0989 USD +0,0026 USD +2,70 %

19:00:03

BTT

Applied Therapeutics jetzt ohne Ordergebühren (zzgl. Spreads) handeln beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)

Jetzt loslegen

Direkt handeln

Bei einem anderen Broker handeln

Marktkap.12,91 Mio. EUR

Div. Rendite0,00%

WKNA2PHHB

ISINUS03828A1016

SymbolAPLT

Applied Therapeutics Aktien News

Sortieren:Datum Meistgelesen

16.12.25ZacksHere's Why Applied Therapeutics (APLT) Is a Great 'Buy the Bottom' Stock Now

27.11.25ZacksApplied Therapeutics (APLT) Upgraded to Buy: Here's Why

13.11.25BenzingaApplied Therapeutics Tanks As FDA Path For Lead Rare-Disease Drug Turns Uncertain

WerbungApplied Therapeutics-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero

14.08.25MotleyFoolApplied Therapeutics Reports Q2 Loss

18.02.25PR NewswireClass Action Filed Against Applied Therapeutics, Inc. (APLT) - February 18, 2025 Deadline to Join - Contact Levi & Korsinsky

11.02.25PR NewswireINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Applied Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - APLT

11.02.25PR NewswireClass Action Filed Against Applied Therapeutics, Inc. (APLT) - February 18, 2025 Deadline to Join - Contact Levi & Korsinsky

04.02.25PR NewswireINVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Applied Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - APLT

04.02.25PR NewswireInvestors in Applied Therapeutics, Inc. Should Contact Levi & Korsinsky Before February 18, 2025 to Discuss Your Rights - APLT

03.02.25PR NewswireApplied Therapeutics, Inc. Sued for Securities Law Violations - Investors Should Contact The Gross Law Firm for More Information - APLT

31.01.25PR NewswireShareholders that lost money on Applied Therapeutics, Inc.(APLT) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More

30.01.25PR NewswireThe Gross Law Firm Reminds Applied Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 18, 2025 - APLT

29.01.25PR NewswireAPLT Lead Plaintiff Deadline Approaching - Contact Robbins LLP for Information About the Pending Class Action Against Applied Therapeutics, Inc.

26.01.25PR NewswireAPLT Purchasers Have Opportunity to Lead Applied Therapeutics, Inc. Securities Fraud Lawsuit

22.01.25PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Applied Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - APLT

21.01.25PR NewswireApplied Therapeutics, Inc. (APLT) Investors Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

21.01.25PR NewswireShareholders that lost money on Applied Therapeutics, Inc.(APLT) should contact Levi & Korsinsky about pending Class Action - APLT

20.01.25PR NewswireShareholders that lost money on Applied Therapeutics, Inc.(APLT) Urged to Join Class Action - Contact The Gross Law Firm to Learn More

16.01.25PR NewswireThe Gross Law Firm Notifies Shareholders of Applied Therapeutics, Inc.(APLT) of a Class Action Lawsuit and an Upcoming Deadline

14.01.25PR NewswireLevi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of February 18, 2025 in Applied Therapeutics, Inc. Lawsuit - APLT

08.01.25PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Applied Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - APLT

08.01.25PR NewswireFaruqi & Faruqi Reminds Applied Therapeutics Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 18, 2025 - APLT

02.01.25PR NewswireInvestors in Applied Therapeutics, Inc. Should Contact The Gross Law Firm Before February 18, 2025 to Discuss Your Rights - APLT

02.01.25EQS GroupEQS-News: Class Action Announcement for Applied Therapeutics, Inc. Investors: A Securities Fraud Class Action Lawsuit Was Filed Against Applied Therapeutics, Inc.

02.01.25PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Applied Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - APLT

29.12.24PR NewswireAPLT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Applied Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

27.12.24PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Applied Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - APLT

27.12.24PR NewswireAPLT INVESTOR DEADLINE: Applied Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

24.12.24PR NewswireAPLT INVESTOR ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In APLT To Contact Him Directly To Discuss Their Options

20.12.24PR NewswireSHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Applied Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines - APLT

20.12.24PR NewswireLost Money on Applied Therapeutics, Inc.(APLT)? Join Class Action Suit Seeking Recovery - Contact Levi & Korsinsky

20.12.24PR NewswireInvestor Notice: Robbins LLP Informs Stockholders of the Class Action Lawsuit Filed Against Applied Therapeutics, Inc.

19.12.24PR NewswireShareholders that lost money on Applied Therapeutics, Inc.(APLT) should contact The Gross Law Firm about pending Class Action - APLT

19.12.24PR NewswireAPLT INVESTOR ALERT: Applied Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

27.06.23PR NewswireSHAREHOLDER ALERT: Purcell & Lefkowitz LLP Is Investigating Applied Therapeutics, Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors

Applied Therapeutics News

Applied Therapeutics News: auf dieser Seite finden Sie alle Applied Therapeutics News und Nachrichten zur Applied Therapeutics Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Applied Therapeutics News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Applied Therapeutics News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.